Tohoku University · Faculty of Pharmaceutical Sciences / Graduate School of Pharmaceutical Sciences · 准教授

Research keywordsCell・Programmed・biology・cell・death・ストレス応答・フェロトーシス・活性酸素

Research fieldsMolecular biology・Cell biology・薬系衛生、生物化学

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• FBXO22 Suppresses Oxidative Stress-Induced ASK1 Activation and Cell Death via Ubiquitination-Dependent Degradation of TRIM48Naoki Kashiwabara, Keita Nagaoka, Kenshin Nakajima, Hiroki Tsukamoto, Yoshihisa Tomioka, Isao Naguro, Hidenori Ichijo, Takuya Noguchi, Yusuke Hirata, Atsushi Matsuzawa
• Post-Translational Modifications of the TAK1-TAB ComplexYusuke Hirata, Miki Takahashi, Tohru Morishita, Takuya Noguchi, Atsushi Matsuzawa
• LLPS of SQSTM1/p62 and NBR1 as outcomes of lysosomal stress response limits cancer cell metastasisTakuya Noguchi, Yuto Sekiguchi, Tatsuya Shimada, Wakana Suzuki, Takumi Yokosawa, Tamaki Itoh, Mayuka Yamada, Midori Suzuki, Reon Kurokawa, Yusuke Hirata, Atsushi Matsuzawa
• Roquin-2 promotes oxidative stress-induced cell death by ubiquitination-dependent degradation of TAK1Yusuke Hirata, Yuya Nakata, Hiromu Komatsu, Yuki Kudoh, Miki Takahashi, Soma Taguchi, Takuya Noguchi, Atsushi Matsuzawa

• 疾患治療への応用を目指した、ASK1のユビキチン化制御機構の解析平田 祐介
• 生体膜脂肪酸環境の感知機構および恒常性維持機構の解明平田 祐介
• トランス脂肪酸関連疾患の発症機序の解明および予防・治療戦略の開発平田 祐介
• トランス脂肪酸による新規細胞死制御機構を基盤としたがん予防・治療戦略の開発平田 祐介

• Official profile